 Company Information |
Listed in:
Pharmaceutical & Medicine Manufacturing
Description:
Labopharm is an emerging pharmaceutical company whose goal is to
become a leading supplier of controlled-release systems to the
pharmaceutical industry worldwide. Its core platform technology,
Contramid, applies to a wide range of medications in solid dosage
forms to improve their oral administration and performance.
Contramid is patented and provides a means to add economic value
to existing products or new chemical entities (NCEs), through
extended patent protection and/or better product differentiation.
Labopharm Inc. (TSX: DDS, NASDAQ:DDSS) is an international, specialty pharmaceutical company focused on the development of drugs incorporating Contramid, the Companys proprietary advanced controlled-release technology. In the last years, Labopharm signed mutiple licensing agreements with international pharmaceutical companies to market on the US, Europe & Latin America a pain controlled-release product developed by Labopharm Inc.
Labopharm is located in the greater Montreal area and benefits
from the region's well-established pharmaceutical infrastructure
which provides access to a number of recognized contract
research and contract manufacturing organizations, as required,
as well as a favourable tax environment.
|
| Map |
|
|
| Products |
 |
Contramid
|
|
|
 |
|